azbiomarkers.bsky.social - Profile | ThreadSky | a Reddit-style client for Bluesky

A very cool thing about getting older in medicine: eventually you see a dreaded disease of your early career succumb to science. Once you witness it a few times, nothing will seem impossible to you in the same way ever again. #MedSky #DrugDevelopment

submitted 1 day ago • 7 comments

🚨 The #AVITI24 Global Grant Program is here! Apply today for your chance to win Teton™ CytoProfiling services from Element Biosciences. 🧬 Simply tell us how you'd use high dimensional multiomics in your research. Apply today: bit.ly/3F64bYc

submitted 2 days ago • 0 comments

🧪 New #sourcerequest: I'm looking to speak with students or early career academics who use AI for data collation, experimental planning, literature review, writing, referencing and statistical analysis. I'd love to hear about the specific tools you use and how you use them.

submitted 9 days ago • 0 comments

The time relegated to being data clerks among US physicians is increasing jamanetwork.com/journals/jam...

submitted 4 days ago • 10 comments

Important implications in the best approach to molecular/minimal residual disease testing in solid tumors: Clonal driver neoantigen loss under EGFR TKI and immune selection pressures www.nature.com/articles/s41...

submitted 6 days ago • 0 comments

Even low levels of ctDNA may signal higher recurrence risk in early-stage lung adenocarcinoma. A new study shows that sensitive tests like NeXT Personal can help personalize treatment & improve outcomes. Early detection is crucial. #LungCancer #ctDNA ascopost.com/news/january...

submitted 10 days ago • 0 comments

New @biorxivpreprint.bsky.social preprint from Amgen induced proximity group and @dannomura.bsky.social lab just posted that describes Covalent Destabilizing Degrader of AR and AR-V7 in Androgen-Independent Prostate Cancer Cells. Read on for an overview 1/7 www.biorxiv.org/content/10.1...

submitted 10 days ago • 1 comment

Functional analysis of cancer-associated germline risk variants www.nature.com/articles/s41...

submitted 10 days ago • 0 comments

Encouraging data in treatment of NRG1 fusion + cancers: Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer www.nejm.org/doi/full/10....

submitted 17 days ago • 0 comments

Gene editing technology began by people studying salt marshes. Ozempic began by folks studying the venom of Gila Monsters. Support for basic science has empowered us to understand our world. Tethering it to applications health has transformed and saved countless lives.

submitted 20 days ago • 53 comments

New from #JCOOA: "Oncologists ... are experiencing higher rates of burnout compared with a decade ago. System-based interventions ... are necessary to maintaining an adequate workforce to provide care for current and future patients..." ascopubs.org/doi/10.1200/... #JCOOA #JCOJournals #OpenAccess

submitted 28 days ago • 0 comments

During WWII the Holocaust killed millions. (Today’s) Poland was most heavily impacted.

submitted 30 days ago • 3 comments

Keep button batteries locked up out of sight and out of reach of kids.

submitted 35 days ago • 27 comments

Data from #ASCOGI25 (society.asco.org/about-asco/p...) shows a 50% decrease in CRC recurrence in a randomized trial at 3yrs. in PIK3CAmut + cancers with daily 160mg dose. Abstract LBA125

submitted 34 days ago • 0 comments

After 80 years, not many Auschwitz survivors are left. One man makes telling the stories his mission.

submitted 35 days ago • 6 comments

Supplement your #GI25 experience with #ASCOEdBook review articles: brnw.ch/21wQeaY

submitted 35 days ago • 0 comments

Come be my boss! We're looking for a new Program Head for the Molecular Medicine Program at the Hospital for Sick Children. Toronto, Canada (the deadline has been extended from Jan 31) Please Re-post. jobs.sciencecareers.org/job/667223/p...

submitted 34 days ago • 1 comment

Article in press in The Journal of Molecular Diagnostics by AMP member Danny Miller and colleagues: Concordance of Whole-Genome Long-Read Sequencing with Standard Clinical Testing for Prader-Willi and Angelman Syndromes Abstract: www.jmdjournal.org/article/S152...

submitted 37 days ago • 0 comments

"Most people trust scientists and agree that scientists should engage more in society and policymaking" From a 68-country assessment. Open-access www.nature.com/articles/s41...

submitted 39 days ago • 22 comments

Not to be missed: #JCOOP comprehensive special issue on #financialtoxicity in #cancercare guest edited by @fumikochino.bsky.social and @ryannipp.bsky.social ascopubs.org/toc/op/current @ascocancer.bsky.social

submitted 44 days ago • 0 comments

Interesting solution to a vexing problem: how do we separate signal from noise in NGS data outputs? removing SNPs w/ VAF less than ~ 0.30 reduces curation T 20% Establishing a Variant Allele Frequency Cutoff for Manual Curation of Medical Exome Sequencing Data www.jmdjournal.org/article/S152...

submitted 48 days ago • 1 comment

Are you a graduate/professional student or early career professional who wants to learn about global development/diplomacy? Apply to Duke's Global Policy Program in Geneva! We have 3 tracks: humanitarian action, global health, trade Priority deadline: Jan 10, 2025 sanford.duke.edu/academics/sp...

submitted 53 days ago • 1 comment

Does coffee prevent head and neck cancer? "Coffee and tea consumption was linked with lower risks of developing head and neck cancers, including cancers of the mouth and throat." Open Access acsjournals.onlinelibrary.wiley.com/doi/full/10....

submitted 59 days ago • 0 comments

Attention Lung Cancer patients! Please participate in this research survey. It only takes about 10 minutes. www.surveymonkey.com/r/37P79WB @devikadasmd.bsky.social @ishwaria.bsky.social #lcsm

submitted 60 days ago • 1 comment

#OncSky #MedSky #PharmSky #MedEd This page summarizing basis of each #cancer drug approval in reverse date order is a great resource for fellows, busy clinicians, & anyone prepping for Boards (or LKA quarterly questions ⏳…). Bookmark & share. www.fda.gov/drugs/resour... #DrugDevelopment

submitted 61 days ago • 2 comments

One of the forgotten costs of cancer therapy is time spent in the clinic. Report on time toxicity in JCO Oncology Practice on pts with lung cancer showed 22% of days alive had in person visits: 24% with chemotherapy, 21% for immunotherapy, 16% for targeted therapy. #LCSM ascopubs.org/doi/10.1200/...

submitted 67 days ago • 1 comment

The BEST part of my day is when I find a NGS report with a targetable mutation! What a time to practice thoracic oncology! #lcsm 🛑 All patients with lung cancer⭐️NEED ⭐️ comprehensive biomarker testing.

submitted 72 days ago • 1 comment

Details on uncommon #EGFR mutations @jtoonline.bsky.social. In 5212 #EGFR NSCLC dataset, 8.9% were uncommon mutations: associated with smoking history, higher rates of EGFR amp and TP53 co-mt, shorter time on TKI (4.1m) vs common (10.9m). #LCSM #OncSky www.jto.org/article/S155...

submitted 73 days ago • 0 comments

🩸Hematopoietic stem cell differentiation with cytokine regulation #hemesky #hemeonc #medsky #IMsky #internalmedicine #hemepath #pathsky #stemcells

submitted 76 days ago • 0 comments

Our "Molecular Medicine for Patients" website has lots of great resources (in English and Spanish) for anyone interested in molecular diagnostics. Give it a look and share it with anyone who'd like to learn what happens in a molecular diagnostic laboratory. outreach.amp.org/

submitted 72 days ago • 0 comments

Three must read papers for PhD students. #scisky #PhD #science #research #academicsky 1. The importance of stupidity in scientific research Open Access journals.biologists.com/jcs/article/...

submitted 96 days ago • 55 comments

#SABCS24 #bcsm #OncSky #SurgSky #MedSky 📣 INSEMA Trial Omission of sentinel node biopsy (SLNB) in pts w/ clin node-neg early #breastcancer did not result in inferior IDFS (@ 6 yrs: 91.7 vs 91.9%). Suggests no SLNB may be👌 for age 50+ w/ gr 1-2, ER+/HER2- tumors, up to 2 cm @oncoalert.bsky.social

submitted 78 days ago • 2 comments